- 17 Dec 2024
- 1 Minute to read
- Print
- DarkLight
URSA-QUALITY-IMACMB2: Immunizations for Adolescents (IMACMB2)
- Updated on 17 Dec 2024
- 1 Minute to read
- Print
- DarkLight
Measure Description
The percentage of adolescents 13 years of age who had one dose of meningococcal vaccine, one tetanus, diphtheria toxoids and acellular pertussis (Tdap) vaccine, and have completed the human papillomavirus (HPV) vaccine series by their 13th birthday. Unadjusted Certified Measure ed0479af-7f8a-414d-ac23-9469cd58f8d6
Metadata
- Measure Type: Rate Measure
- Temporal Structure: Entity
- Component Class: Normal-Form
- Denominator Case Field: Patient ID, Output NCQA Payer Type Code
- Target Direction: Up
Denominator Description
Adolescents who turn 13 years of age during the measurement year.
Numerator Description
Qualifying denominator patients with one dose of meningococcal vaccine, one tetanus, diphtheria toxoids and acellular pertussis (Tdap) vaccine, and have completed the human papillomavirus (HPV) vaccine series by their 13th birthday.
HEDISĀ® is a registered trademark of the National Committee for Quality Assurance (NCQA).